Nasal spray flu vaccine approved for home use: Here’s what to know
The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca, was announced last week and can be used by adults aged 49 and under.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
If this flu-busting nasal spray lives up to its promise, it will be a blockbuster. Scientists at Harvard Medical School have ...
On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray ...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
Axios Vitals on MSN4d
At-home nasal spray flu vaccine coming next yearA nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback